Study on Inhibitory Effect of Endostatin Gene Combined with Recombinant IFN-α Protein on Ovarian Cancer

魏增涛,卢爱英,王晓燕,马春红,孙汶生,张艳,朱法良,郭春
DOI: https://doi.org/10.3969/j.issn.1003-6946.2005.10.008
2005-01-01
Abstract:Objective: To study inhibitory effect of endostatin gene combined with recombinant IFN-α protein on transplantation tumor of ovarian cancer. Methods: 3AO cells line were used to prepare ovarian cancer animal model, recombinant IFN-α combined with lipofectin mediated pVAX-sEn were injected intra-tumor and peri-tumor, the volumes of tumor were measured two times one week; Flow Cytometry and histoimmnochemical assay was used to detect the effect of pVAX-sEn on tumor cell cycle and microvessels density of tumor tissue, respectively. Results: The tumor volumes in the combined treatment group were significantly smaller than those in pVAX-sEn treatment group (P(0.01); The apoptosis rate of tumor cells in combined treatment group was 18.5%, which was higher than that in pVAX-sEn treatment group; There were obviously necrosis of tumor cells with fewer blood vessels in combined treatment group. The microvessels density in combined treatment group was 3.16±1.12, which was significantly lower than pVAX-sEn treatment group (P0.01). Conclusions: Lipofectin mediated pVAX-sEn gene expressing intra-tumor can effectively inhibit the growth of transplantation tumor of ovarian cancer, the inhibitory effect is better when combined with recombinant IFN-α.
What problem does this paper attempt to address?